Posted on 9/12/17
Alexion Announces Restructuring to Advance Corporate Strategy
NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced an operational plan to re-align the global organization with its refocused corporate strategy. The plan is expected . . .
Posted on 9/12/17
Why Biogen Stock Raced Higher In August
What happenedBiotech titan Biogen (NASDAQ:BIIB) saw its shares rise by 8.73% last month, according to data from S&P Global Market Intelligence. This healthy march northward was . . .
Posted on 9/12/17
Boston Children's Hospital and Boston Pediatric Device Consortium Launch Pediatric Medical Device Challenge
The Innovation and Digital Health Accelerator (IDHA) at Boston Children's Hospital and the Boston Pediatric Device Consortium (BPDC) today announced a call for applications for the . . .
Posted on 9/11/17
Innovation Pharmaceuticals Secures New $30 Million Common Stock Purchase Agreement
BEVERLY, Mass., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc., (OTCQB:IPIX), a clinical stage biopharmaceutical company, today announces that the Company has entered into a . . .
Posted on 9/11/17
Here's Why the Best Is Yet to Come for Cara Therapeutics, Inc.
By late June, Cara Therapeutics, Inc. (NASDAQ:CARA) stock had soared more than 175% year to date. Within a couple of weeks, however, many of those gains . . .
Posted on 9/11/17
Why I Love Berkshire Hathaway
It's the investment vehicle of arguably the most legendary investor in the world, its portfolio never seems to stop growing, and its historical returns have been . . .
Posted on 9/11/17
Akebia Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 9/8/17
Why Gene-Editing Pioneer Editas Skyrocketed 28.8% in August
What happenedEditas Medicine (NASDAQ:EDIT) is researching the use of gene editing to treat disease. After the company updated investors on its progress on Aug. 9, shares . . .
Posted on 9/7/17
mProve Health and Greenphire Partner
DPharm: Disruptive Innovations to Advance Clinical Trials -- mProve Health, a leading provider of mobile technologies for patient engagement and electronic clinical outcome assessments (eCOA), and . . .
Posted on 9/6/17
Bioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration
WALTHAM, Mass. & CAMBRIDGE, England--(BUSINESS WIRE)--Bioverativ Inc. (NASDAQ: BIVV), a global biotechnology company focused on the discovery, development and commercialization of innovative therapies for hemophilia and . . .
Posted on 9/6/17
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced that, on September 1, . . .
Posted on 9/6/17
Akcea Therapeutics Establishes Canadian Subsidiary
CAMBRIDGE, Mass., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat . . .
Posted on 9/5/17
Cyft and MedMinder Partner
MedMinder and Cyft are proud to announce a new partnership to improve care management for chronic / complex populations. Cyft uses AI to help care management . . .
Posted on 9/5/17
Pulmatrix Receives Award from Cystic Fibrosis Foundation Therapeutics
Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it has received an award . . .
Posted on 9/5/17
American Diabetes Association and Good Measures Collaborate
BOSTON--(BUSINESS WIRE)--The American Diabetes Association® and Good Measures, LLC today announced a new collaboration to help prevent and delay the onset of type 2 diabetes in . . .
Posted on 9/5/17
Warren Buffett Is Now the Biggest Shareholder of 2 Massive Banks
The most important person in the bank industry isn't a banker -- it's Warren Buffett, the chairman and CEO of Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B).He cemented that . . .
Posted on 9/4/17
ImmunoGen Announces Agreements to Exchange $76.4M of Its 4.50% Convertible Senior Notes
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ:IMGN) announced that it has entered into privately negotiated exchange agreements with a limited number of holders of its 4.50% Convertible Senior . . .
Posted on 9/4/17
Local Communities Dissatisfaction Continues with CHS and QHC
OAKLAND, Calif.--(BUSINESS WIRE)--On the same day this week, community members and nurses in cities in Florida and Maine expressed deep concern and dissatisfaction with the way . . .
Posted on 9/1/17
What About A Bristol-Myers Squibb Takeover By Pfizer?
Pfizer (PFE) has a history of making big acquisitions, and has access to very cheap cash right now -- this would allow the company to make . . .
Posted on 9/1/17
Why Teva Pharmaceutical Industries, Shoe Carnival, and Hasbro Jumped Today
The major benchmarks all moved higher Thursday, with the Nasdaq Composite producing the biggest gains. The growing devastation left in the wake of Hurricane Harvey still . . .
Posted on 9/1/17
Nightstar Files Registration Statement For Proposed IPO
LEXINGTON, Mass. & LONDON--(BUSINESS WIRE)--Nightstar Therapeutics Limited, a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced that it has filed a . . .
Posted on 8/31/17
Celgene Has Led Bluebird Into A Crowded Field
Two years ago, when Lenti-D and LentiGlobin were still its lead product candidates, I viewed bluebird bio (BLUE) as industry leader in the development of gene . . .
Posted on 8/31/17
Immunogen Inks Jazz Deal: Moves To Push Tech To Limits
On Tuesday, Immunogen (IMGN) announced that it had inked a partnership deal with Jazz Pharmaceuticals (JAZZ). This partnership will allow Jazz to help develop Immunogen's anti-body . . .
Posted on 8/31/17
Why Investors Bid Immunogen Inc. Up Almost 12% Today
What happenedNews that Irish biotech Jazz Pharmaceuticals (NASDAQ:JAZZ) had signed on to collaborate with Immunogen Inc. (NASDAQ:IMGN)in the development of drugs in the smaller, Massachusetts-based company's . . .
Posted on 8/30/17
Jazz Pharmaceuticals and ImmunoGen Announce a Strategic Collaboration
DUBLIN & WALTHAM, Mass.--(BUSINESS WIRE)--Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and ImmunoGen, Inc. (Nasdaq: IMGN) today announced that the companies have entered into a collaboration and option . . .
Boston
